Nightingale Health’s technology used to analyze Uganda’s General Population Cohort (GPC)
Press release, 19 March 2024 at 8:00 a.m. (EET) Nightingale Health Plc (“Nightingale Health”), a pioneer in health risk detection and preventative health, has entered into an agreement in which it will analyze blood samples from Uganda’s General Population Cohort (GPC). The GPC is a population-based study of approximately 22,000 individuals residing in southwestern Uganda. The study represents ten ethnolinguistic groupings and is the first from the region to be analyzed by Nightingale Health’s technology. It has been widely suggested that ethnic differences play a role in the